Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J García Frade

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Revista Clinica Espanola|June 1, 1993
[Current status of thrombolysis. The need for coadjuvant antithrombotic therapy]L J García Frade, A García Avello
Thrombosis Research|September 1, 1994
High plasma levels of plasminogen activator inhibitor 1 (PAI-1) in polycythemia vera and essential thrombocythemia are associated with thrombosisJ A Cancelas, A García-Avello, L J García-Frade
Revista Clinica Espanola|February 1, 1989
[Thrombolytic agents: efficacy in relation to evolution time and dose]L J García Frade, M C Torrado, M Loren, et al.
Acta Haematologica|January 1, 1992
High plasma urokinase-type plasminogen activator levels are present in patients with acute nonlymphoblastic leukemiaL J García Frade, A Sureda, M C Torrado, et al.
Thrombosis Research|October 1, 1989
Thrombus age and tissue plasminogen activator mediated thrombolysis in ratsM Loren, L J García Frade, M C Torrado, et al.
Sangre|August 1, 1994
[Familial thrombophilia due to resistance to activated protein C]V Cuevas, J I Tortosa, C Rodríguez, et al.
Revista Espanola De Fisiologia|December 1, 1986
[Purification of fibronectin using gelatin derivatives]R M Tolón, T Obispo, I Alava, et al.
Acta Haematologica|January 1, 1992
A continuous spectrum of hypercoagulability exists in acute nonlymphoblastic leukemiaA Sureda, L J García Frade, M C Torrado, et al.
Revista Clinica Espanola|March 1, 1991
[Hemostasis profiles in thrombotic disease]A García Avello, L J García Frade, P Ortiz, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1995
Efficacy of D-dimer and total fibrin degradation products evaluation in suspected pulmonary embolismJ Flores, C Lancha, E Pérez Rodríguez, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Revista Clinica Espanola|June 1, 1993
[Current status of thrombolysis. The need for coadjuvant antithrombotic therapy]L J García Frade, A García Avello
Thrombosis Research|September 1, 1994
High plasma levels of plasminogen activator inhibitor 1 (PAI-1) in polycythemia vera and essential thrombocythemia are associated with thrombosisJ A Cancelas, A García-Avello, L J García-Frade
Revista Clinica Espanola|February 1, 1989
[Thrombolytic agents: efficacy in relation to evolution time and dose]L J García Frade, M C Torrado, M Loren, et al.
Acta Haematologica|January 1, 1992
High plasma urokinase-type plasminogen activator levels are present in patients with acute nonlymphoblastic leukemiaL J García Frade, A Sureda, M C Torrado, et al.
Thrombosis Research|October 1, 1989
Thrombus age and tissue plasminogen activator mediated thrombolysis in ratsM Loren, L J García Frade, M C Torrado, et al.
Sangre|August 1, 1994
[Familial thrombophilia due to resistance to activated protein C]V Cuevas, J I Tortosa, C Rodríguez, et al.
Revista Espanola De Fisiologia|December 1, 1986
[Purification of fibronectin using gelatin derivatives]R M Tolón, T Obispo, I Alava, et al.
Acta Haematologica|January 1, 1992
A continuous spectrum of hypercoagulability exists in acute nonlymphoblastic leukemiaA Sureda, L J García Frade, M C Torrado, et al.
Revista Clinica Espanola|March 1, 1991
[Hemostasis profiles in thrombotic disease]A García Avello, L J García Frade, P Ortiz, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1995
Efficacy of D-dimer and total fibrin degradation products evaluation in suspected pulmonary embolismJ Flores, C Lancha, E Pérez Rodríguez, et al.
Pageof 2